Page last updated: 2024-10-28

hexobarbital and Porphyrias

hexobarbital has been researched along with Porphyrias in 2 studies

Hexobarbital: A barbiturate that is effective as a hypnotic and sedative.
hexobarbital : A member of the class of barbiturates taht is barbituric acid substituted at N-1 by methyl and at C-5 by methyl and cyclohex-1-enyl groups.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Poland, A1
Goldstein, J1
Hickman, P1
Burse, VW1
De Matteis, F1

Other Studies

2 other studies available for hexobarbital and Porphyrias

ArticleYear
A reciprocal relationship between the induction of -aminolevulinic acid synthetase and drug metabolism produced by m-dichlorobenzene.
    Biochemical pharmacology, 1971, Volume: 20, Issue:6

    Topics: Acyltransferases; Animals; Benzene Derivatives; Body Weight; Chemical and Drug Induced Liver Injury;

1971
Hypercholesterolaemia and liver enlargement in experimental hepatic porphyria.
    The Biochemical journal, 1966, Volume: 98, Issue:2

    Topics: Alcohol Oxidoreductases; Animals; Chlorobutanol; Cholesterol; Glucosephosphate Dehydrogenase; Griseo

1966